These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7881229)

  • 1. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care.
    Branford D
    J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():577-86. PubMed ID: 7881229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of community and institutional prescription of antiepileptic drugs for individuals with learning disabilities.
    Branford D; Collacott RA
    J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():561-6. PubMed ID: 7881227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prescribing of neuroleptic drugs for people with learning disabilities living in Leicestershire.
    Branford D; Collacott RA; Thorp C
    J Intellect Disabil Res; 1995 Dec; 39 ( Pt 6)():495-500. PubMed ID: 8746736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England.
    Branford D; Sun JJ; Shankar R
    Br J Psychiatry; 2023 May; 222(5):191-195. PubMed ID: 36786124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant prescribing for adult people with an intellectual disability living in England.
    Branford D; Shankar R
    Br J Psychiatry; 2022 Aug; 221(2):488-493. PubMed ID: 35249557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire.
    Branford D
    J Intellect Disabil Res; 1996 Aug; 40 ( Pt 4)():358-68. PubMed ID: 8884591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability.
    Christian L; Snycerski SM; Singh NN; Poling A
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():88-93. PubMed ID: 10221788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
    Hogg J
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
    Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
    BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
    [No Abstract]   [Full Text] [Related]  

  • 15. A follow-up study of prescribing for people with learning disabilities previously in National Health Service care in Leicestershire, England.
    Branford D
    J Intellect Disabil Res; 1997 Aug; 41 ( Pt 4)():339-45. PubMed ID: 9297613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
    Shankar R; Wilcock M
    PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour.
    Kiernan C; Reeves D; Alborz A
    J Intellect Disabil Res; 1995 Aug; 39 ( Pt 4)():263-74. PubMed ID: 7579984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmentally disabled, doubly disadvantaged.
    Parker G
    Med J Aust; 1991 Jul; 155(2):68-71. PubMed ID: 1857308
    [No Abstract]   [Full Text] [Related]  

  • 20. Unnecessary psychotropic drug prescription in primary care for people with intellectual disability.
    Trollor J; Salomon C
    Evid Based Ment Health; 2016 May; 19(2):62. PubMed ID: 27075445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.